ABPN Neurology Pilot Project Articles

Neurology

Article-Assessment Program Article List

Updated: February 2021

The following articles are being used in the American Board of Psychiatry and Neurology's Article Assessment program for the current year. Please note that these articles are subject to change without notice. Please consult the ABPN Continuing Certification testing site for the most up-to-date information about articles that are currently active.

The articles listed are subject to change. Please note that pay status is also subject to change and is set by the publisher of the journal. ABPN has no control over the cost of journal articles. If you are having trouble accessing articles listed free to professional society members, please contact the professional society directly for assistance. When accessing articles from publisher websites, we recommend that you download a copy of a file once and consult that copy when taking exams. Some sites may limit the amount of articles that you can access per month without a subscription; in those cases, downloading or viewing an article repeatedly may cause you to be blocked from accessing any articles until the next month begins. Some or all of these articles may be protected by copyright. Please refer to the publisher's copyright notice and policies.

? 2021, American Board of Psychiatry and Neurology, Inc. All rights reserved.

Last Revision Date: February 9, 2021

1

Topic 1: Headache and Pain Disorders

1 Deen M, Correnti E, Kamm K, et al.

Blocking CGRP in migraine patients - a review of pros and cons The Journal of Headache and Pain 2017; 18(1)

No cost

2 Hoffman J, May A

Diagnosis, pathophysiology, and management of cluster headache The Lancet Neurology 2018; 17(1):75-83

Purchase May Be Required

3 Cruccu G, Finnerup NB, Jensen TS, et al.

No cost

Trigeminal neuralgia: New classification and diagnostic grading for practice and

research

Neurology

2016; 87(2):220-228

4 Calhoun AH, Batur P

Combined hormonal contraceptives and migraine: An update on the evidence Cleveland Clinic Journal of Medicine 2017; 84(8):631-638

Purchase May Be Required

5 Kranz PG, Gray L, Amrhein TJ

Spontaneous Intracranial Hypotension: 10 Myths and Misperceptions Headache 2018; 58:948-959

Purchase May Be Required

6 Vandenbussche N, Laterza D, Lisicki M, et al.

Medication-overuse headache: a widely recognized entity amidst ongoing debate Journal of Headache and Pain 2018 Jul 13;19(1):50

No cost

2

Topic 2: Epilepsy and Episodic Disorders, Sleep Disorders

1 Chen Z, Brodie MJ, Liew D, et al.

Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: A 30-year longitudinal cohort study JAMA Neurology 2018; 75(3):279-286

2 Trotti, LM

Restless legs syndrome and sleep-related movement disorders Continuum 2017; 23(4):1005-1016

3 Pennell PB

Use of antiepileptic drugs during pregnancy: Evolving concepts Neurotherapeutics 2016; 13(4):811-820

4 Harden C, Tomson T, Gloss D, et al.

Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society Neurology 2017; 88(17):1674-1680

5 Quek AML, O'Toole O

Autoimmune Epilepsy: The Evolving Science of Neural Autoimmunity and Its Impact on Epilepsy Management Seminars in Neurology 2018 Jun;38(3):290-302

6 Vakharia VN, Duncan JS, Witt JA, et al.

Getting the Best Outcomes from Epilepsy Surgery Annals of Neurology 2018;83:676?690

No cost

No cost No cost No cost

Purchase May Be Required No cost

3

Topic 3: Vascular Neurology

1 Gurol ME

Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk Stroke 2018 Jan;49(1):247-254

2 Johnston SC, Easton JD, Farrant M, et al.

Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA New England Journal of Medicine 2018; 379:215-225

3 Saver JL

Cryptogenic stroke The New England Journal of Medicine 2016; 374:2065-2074

4 Ntaios G, Papavasileiou V, Sagris D, et al.

Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: Updated systematic review and meta-analysis Stroke 2018; 49(2):412-418

5 Horne MA, Flemming KD, Su IC, et al.

Clinical course of untreated cerebral cavernous malformations: A metaanalysis of individual patient data The Lancet Neurology 2016; 15(2): 166-173

6 Nogueira RG, Jadhav AP, Haussen DC, et al.

Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct The New England Journal of Medicine 2018; 378(1):11-21

No cost No cost No cost No cost No cost No cost

4

Topic 4: Neuromuscular Diseases

1 Wolfe GI, Kaminski HJ, Aban IB, et al.

Randomized Trial of Thymectomy in Myasthenia Gravis New England Journal of Medicine 2016;375:511-22

No cost

2 Wurster C, Ludolph AC

Antisense oligonucleotides in neurological disorders Therapeutic Advances in Neurological Disorders 2018, Vol. 11: 1?19

No cost

3 Nicholson K, Murphy A, McDonnell E, et al.

Purchase

Improving symptom management for people with amyotrophic lateral sclerosis May Be

Muscle & Nerve

Required

2018; 57(1):20-24

4 Willison HJ, Jacobs BC, van Doorn PA

Guillain-Barre syndrome The Lancet 2016; 388(10045):717-727

No cost

5 Sanders DB, Wolfe GI, Benatar M, et al.

International consensus guidance for management of myasthenia gravis: Executive summary Neurology 2016; 87(4): 419-425

No cost

6 Terkelsen AJ, Karlsson P, Lauria G, et al.

The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes The Lancet Neurology 2017; 16(11):934-944

Purchase May Be Required

5

Topic 5: Movement Disorders

1 Kieburtz K, Reilmann R, Olanow CW

Huntington's Disease: Current and Future Therapeutic Prospects Movement Disorders 2018 Jul;33(7):1033-1041

Purchase May Be Required

2 Morgan JC, Fox SH

Treating the motor symptoms of Parkinson disease Continuum 2016; 22(4):1064-85

No cost

3 Turcano P, Mielke MM, Bower JH, et al.

Levodopa-induced dyskinesia in Parkinson disease: A population-based cohort

Free to AAN

study.

members

Neurology

2018 Dec 11;91(24):e2238-e2243

4 Boxer AL, Yu JT, Golbe LI, et al.

Advances in progressive supranuclear palsy: New diagnostic criteria, biomarkers, and therapeutic approaches The Lancet Neurology 2017; 16(7):552-563

Purchase May Be Required

5 Simpson DM, Hallett M, Ashman EJ, et al.

No cost

Practice guideline update summary: Botulinum neurotoxin for the treatment of

blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the

Guideline Development Subcommittee of the American Academy of Neurology

Neurology

2016; 86(19):1818-1826

6 Cury RG, Fraix V, Castrioto A, et al.

Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia Neurology 2017; 89(13):1416-1423

Free to AAN

members

6

Topic 6: Neuro-oncology, Neuroimmunologic and Paraneoplastic Disorders of CNS, Neuroinfectious Diseases

1 Graus F, Titulaer MJ, Balu R, et al.

A clinical approach to diagnosis of autoimmune encephalitis The Lancet Neurology 2016; 15(4):391-404

2 Thompson AJ, Baranzini SE, Geurts J, et al.

Multiple sclerosis The Lancet 2018; 391(10130):1622-1636

3 Thakur KT, Wilson MR

Chronic Meningitis Continuum 2018 Oct;24(5, Neuroinfectious Disease):1298-1326

4 Reitman ZJ, Winkler F, Elia AEH

New Directions in the Treatment of Glioblastoma Seminars in Neurology 2018 Feb;38(1):50-61

5 Lin X, DeAngelis LM

Treatment of brain metastases Journal of Clinical Oncology 2015; 33(30): 3475-3484

6 Thompson AJ, Banwell BL, Barkhof F, et al.

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria The Lancet Neurology 2018; 17(2):162-173

No cost

Purchase May Be Required

No cost

Purchase May Be Required

Purchase May Be Required

Purchase May Be Required

7

Topic 7: Behavioral Neurology, Psychiatric Disorders

1 Rabinovici GD, Gatsonis C, Apgar C, et al.

Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia JAMA 2019 Apr 2;321(13):1286-1294

2 Girard TD, Exline MC, Carson SS, et al.

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness New England Journal of Medicine 2018 Dec 27;379(26):2506-2516

3 Elahi FM, Miller BL

A clinicopathological approach to the diagnosis of dementia Nature Reviews Neurology 2017; 13(8):457-476

4 Mead S, Rudge P

CJD mimics and chameleons Practical Neurology 2017; 17(2):113-121

5 Rakofsky J, Rapaport M

Mood Disorders Continuum 2018 Jun; 24 (3)

6 McKeith IG, Boeve BF, Dickson DW, et al.

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium Neurology 2017; 89(1):88-100

No cost

No cost No cost No cost No cost No cost

8

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download